IL145279A0 - Antibodies against caspase-8, their preparation and use - Google Patents

Antibodies against caspase-8, their preparation and use

Info

Publication number
IL145279A0
IL145279A0 IL14527901A IL14527901A IL145279A0 IL 145279 A0 IL145279 A0 IL 145279A0 IL 14527901 A IL14527901 A IL 14527901A IL 14527901 A IL14527901 A IL 14527901A IL 145279 A0 IL145279 A0 IL 145279A0
Authority
IL
Israel
Prior art keywords
preparation
antibodies against
against caspase
caspase
antibodies
Prior art date
Application number
IL14527901A
Other languages
English (en)
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Priority to IL14527901A priority Critical patent/IL145279A0/xx
Priority to UA2004042509A priority patent/UA78526C2/uk
Publication of IL145279A0 publication Critical patent/IL145279A0/xx
Priority to SI200230395T priority patent/SI1423429T1/sl
Priority to MXPA04002104A priority patent/MXPA04002104A/es
Priority to EP02762749A priority patent/EP1423429B1/en
Priority to IL16066102A priority patent/IL160661A0/xx
Priority to ES02762749T priority patent/ES2265511T3/es
Priority to DK02762749T priority patent/DK1423429T3/da
Priority to KR10-2004-7003217A priority patent/KR20040044535A/ko
Priority to EP06014417A priority patent/EP1770101A1/en
Priority to DE60213827T priority patent/DE60213827T2/de
Priority to AT02762749T priority patent/ATE335766T1/de
Priority to CNA028219678A priority patent/CN1599755A/zh
Priority to PCT/IL2002/000734 priority patent/WO2003020767A2/en
Priority to EA200400393A priority patent/EA009770B1/ru
Priority to PT02762749T priority patent/PT1423429E/pt
Priority to CA002458985A priority patent/CA2458985A1/en
Priority to BR0212289-8A priority patent/BR0212289A/pt
Priority to JP2003525037A priority patent/JP2005501905A/ja
Priority to US10/488,608 priority patent/US20050058648A1/en
Priority to CY20061101481T priority patent/CY1106200T1/el
Priority to US11/745,949 priority patent/US20080311599A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL14527901A 2001-09-04 2001-09-04 Antibodies against caspase-8, their preparation and use IL145279A0 (en)

Priority Applications (22)

Application Number Priority Date Filing Date Title
IL14527901A IL145279A0 (en) 2001-09-04 2001-09-04 Antibodies against caspase-8, their preparation and use
UA2004042509A UA78526C2 (en) 2001-09-04 2002-04-09 Antibody against caspase-8, a process for preparation and use of said antibody for development of elisa-analysis
US10/488,608 US20050058648A1 (en) 2001-09-04 2002-09-04 Antibodies against caspase-8, their preparation and use
DE60213827T DE60213827T2 (de) 2001-09-04 2002-09-04 Antikörper gegen Caspase-8, ihre Herstellung und Verwendung
AT02762749T ATE335766T1 (de) 2001-09-04 2002-09-04 Antikörper gegen caspase-8, ihre herstellung und verwendung
EP02762749A EP1423429B1 (en) 2001-09-04 2002-09-04 Antibodies against caspase-8, their preparation and use
IL16066102A IL160661A0 (en) 2001-09-04 2002-09-04 Antibodies against caspase-8, their preparation and use
ES02762749T ES2265511T3 (es) 2001-09-04 2002-09-04 Anticuerpos contra la caspasa-8, su preparacion y su uso.
DK02762749T DK1423429T3 (da) 2001-09-04 2002-09-04 Antistoffer mod caspase-8 og deres fremstilling og anvendelse
KR10-2004-7003217A KR20040044535A (ko) 2001-09-04 2002-09-04 카스파제-8에 대한 항체, 이들의 제조 및 용도
EP06014417A EP1770101A1 (en) 2001-09-04 2002-09-04 Antibodies against caspase-8, their preparation and use
SI200230395T SI1423429T1 (sl) 2001-09-04 2002-09-04 Protitelesa proti kaspazi-8, njihova priprava in uporaba
MXPA04002104A MXPA04002104A (es) 2001-09-04 2002-09-04 Anticuerpos contra caspasa-8, su preparacion y uso.
CNA028219678A CN1599755A (zh) 2001-09-04 2002-09-04 抗天冬氨酸特异半胱氨酸蛋白酶－8的抗体,其制备方法及应用
PCT/IL2002/000734 WO2003020767A2 (en) 2001-09-04 2002-09-04 Antibodies against caspase-8, their preparation and use
EA200400393A EA009770B1 (ru) 2001-09-04 2002-09-04 Антитела против каспазы-8 и способы их получения и применения
PT02762749T PT1423429E (pt) 2001-09-04 2002-09-04 Espirociclico-6, 7-di-idro-5h-pirazolo [1, 2-a]pirazol-1-onas que controlam citocinas inflamatórias
CA002458985A CA2458985A1 (en) 2001-09-04 2002-09-04 Antibodies against caspase-8, their preparation and use
BR0212289-8A BR0212289A (pt) 2001-09-04 2002-09-04 Anticorpos contra caspase-8, preparação e uso do mesmo
JP2003525037A JP2005501905A (ja) 2001-09-04 2002-09-04 カスパーゼ−８に対する抗体、その調製物および使用
CY20061101481T CY1106200T1 (el) 2001-09-04 2006-10-16 Αντισωματα εναντια σε κασπαση-8, παρασκευη και χρηση τους
US11/745,949 US20080311599A1 (en) 2001-09-04 2007-05-08 Antibodies against caspase-8, their preparation and use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL14527901A IL145279A0 (en) 2001-09-04 2001-09-04 Antibodies against caspase-8, their preparation and use

Publications (1)

Publication Number Publication Date
IL145279A0 true IL145279A0 (en) 2002-06-30

Family

ID=11075764

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14527901A IL145279A0 (en) 2001-09-04 2001-09-04 Antibodies against caspase-8, their preparation and use

Country Status (18)

Country Link
US (2) US20050058648A1 (xx)
EP (2) EP1770101A1 (xx)
JP (1) JP2005501905A (xx)
KR (1) KR20040044535A (xx)
CN (1) CN1599755A (xx)
AT (1) ATE335766T1 (xx)
BR (1) BR0212289A (xx)
CA (1) CA2458985A1 (xx)
CY (1) CY1106200T1 (xx)
DE (1) DE60213827T2 (xx)
DK (1) DK1423429T3 (xx)
EA (1) EA009770B1 (xx)
ES (1) ES2265511T3 (xx)
IL (1) IL145279A0 (xx)
MX (1) MXPA04002104A (xx)
PT (1) PT1423429E (xx)
UA (1) UA78526C2 (xx)
WO (1) WO2003020767A2 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL158599A0 (en) * 2003-10-26 2004-05-12 Yeda Res & Dev Methods of modulating hematopoiesis
US7838645B2 (en) * 2004-04-30 2010-11-23 University Of Maryland College Park Function of autophagy genes in cell death
WO2011049350A2 (ko) * 2009-10-19 2011-04-28 한올바이오파마주식회사 변형된 인간 종양 괴사 인자 수용체-1 폴리펩티드 또는 그의 절편 및 그의 제조방법
CN106146665B (zh) * 2016-08-31 2019-08-09 中国农业科学院植物保护研究所 一种用于制备针对甜菜夜蛾caspase-5大亚基的抗体的方法
CN112255061A (zh) * 2020-10-13 2021-01-22 南开大学 一种通过免疫沉淀分离和检测蛋白质的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
WO2000077201A1 (en) * 1999-06-15 2000-12-21 Astrazeneca Ab Livin; inhibitor-of-apoptosis protein-3 (iap-3)
FR2878852B1 (fr) * 2000-09-28 2007-02-23 Imtix Sangstat Procede de production d'immunoglobulines anti-thymocytes humains

Also Published As

Publication number Publication date
MXPA04002104A (es) 2004-06-07
US20050058648A1 (en) 2005-03-17
CN1599755A (zh) 2005-03-23
EA200400393A1 (ru) 2004-08-26
EA009770B1 (ru) 2008-04-28
ES2265511T3 (es) 2007-02-16
EP1423429B1 (en) 2006-08-09
CY1106200T1 (el) 2011-06-08
JP2005501905A (ja) 2005-01-20
KR20040044535A (ko) 2004-05-28
WO2003020767A9 (en) 2004-04-15
CA2458985A1 (en) 2003-03-13
UA78526C2 (en) 2007-04-10
EP1770101A1 (en) 2007-04-04
DK1423429T3 (da) 2006-09-04
WO2003020767A3 (en) 2003-10-02
PT1423429E (pt) 2006-12-29
BR0212289A (pt) 2004-09-14
DE60213827D1 (de) 2006-09-21
WO2003020767A2 (en) 2003-03-13
ATE335766T1 (de) 2006-09-15
EP1423429A2 (en) 2004-06-02
DE60213827T2 (de) 2007-03-29
US20080311599A1 (en) 2008-12-18

Similar Documents

Publication Publication Date Title
MXPA03007319A (es) Anticuerpos contra egfr modificados, con inmunogenicidad reducida.
MXPA03008961A (es) Composicion de vacuna.
ZA200208561B (en) Hydraulischer druckverstarker.
HK1051639A1 (en) Buckle.
MXPA03004932A (es) 2-anilino-bencimidazoles sustituidos y su uso como inhibidores de nhe.
MXPA01009037A (es) I-bet.
DE60120712D1 (en) Kallikrein gen
MXPA03009167A (es) PRODUCTO ABSORBENTE CON ADAPTACIoN MEJORADA.
MXPA03009698A (es) Vacuna multivalente que comprende un antigeno vih y un antigeno vsh y/o un antigeno vph.
ZA200208648B (en) Metal-polyurethane laminates.
MXPA03007693A (es) Composicion para la piel.
MXPA03008164A (es) Agentes anti-epileptogenos.
MXPA03009204A (es) PRODUCTO ABSORBENTE CON ADAPTACIoN MEJORADA.
MXPA03007437A (es) Conjugados de pregabalina-lactosa.
EG23378A (en) Composition.
MXPA03006041A (es) Tratamientos de antiensuciamiento.
MXPA03001783A (es) N-(3,5-dicloro-2-metoxifenil)-4-metoxi-3- piperazin-1 -il -bencenosulfonamida.
IL162310A0 (en) 3,4-Dihydro-1h-isoquinoloin-2-yl-derivatives
IL145279A0 (en) Antibodies against caspase-8, their preparation and use
MXPA03008077A (es) Composicion humedecedora para la piel..
GB0217548D0 (en) Four human zinc-finger-containing proteins:MDZ3.MDZ4,MDZ7 and MDZ12
HK1057551A1 (en) Substituted 3,4-dihydro-pyridoÄ1,2-AÜpyrimidines.
GB2379929B (en) I. S. machine
AUPR246301A0 (en) F.l.o.e.s, s.p.l.s.d
IL160661A0 (en) Antibodies against caspase-8, their preparation and use